Genetic and non-genetic factors affecting the response to clopidogrel therapy.
about
Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety.Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of ClopidogrelAssociation of P2Y12 gene promoter DNA methylation with the risk of clopidogrel resistance in coronary artery disease patients.Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials.Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients.P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy.Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA.The discovery and development of prasugrel.Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
P2860
Q34805121-419D042D-974C-49A3-96C7-19432FDE2E16Q37506535-9C6ECE01-41EB-4E83-A475-2258D7CC473BQ37639546-4788217B-5D6B-4610-811F-19F5D290C48FQ37686892-8A5AD88D-CE3B-4485-9709-7E832576B44BQ38817051-050744E5-FA4A-451A-912A-1F4F49C66EF0Q38974884-FFE6FD10-FE9F-4DB2-852A-3EB7BE4A9874Q41242987-87CD1C15-B363-47E1-BA87-1B68AD1B7A6DQ41511099-37C1CBA2-FC98-4E96-B065-96198A31043CQ47094164-B590DDEC-8005-4BEA-8772-B6CA2AAF22EFQ51059883-9ECA52B4-CFCF-41FC-AD9D-6C076FEFC09EQ51342808-03FF1BDD-7660-47A0-B48B-30844D263EB1Q51816112-28E131A7-B7C0-4BBF-A0E8-F6158E31A073Q53584028-C5266B21-343E-4D6B-AF1A-2AE68E8D9CEC
P2860
Genetic and non-genetic factors affecting the response to clopidogrel therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetic and non-genetic factors affecting the response to clopidogrel therapy.
@en
Genetic and non-genetic factors affecting the response to clopidogrel therapy.
@nl
type
label
Genetic and non-genetic factors affecting the response to clopidogrel therapy.
@en
Genetic and non-genetic factors affecting the response to clopidogrel therapy.
@nl
prefLabel
Genetic and non-genetic factors affecting the response to clopidogrel therapy.
@en
Genetic and non-genetic factors affecting the response to clopidogrel therapy.
@nl
P2860
P1476
Genetic and non-genetic factors affecting the response to clopidogrel therapy
@en
P2093
Franciszek Główka
P2860
P304
P356
10.1517/14656566.2012.666524
P407
P577
2012-03-07T00:00:00Z